Impact of surgical resection in recurrent brain metastases from lung cancer

M. Al-Zabin, M. Proescholdt, W. Ullrich & A. Brawanski
Objective: Brain metastases develop in 25% of patients with lung cancer during the course of their disease, accounting for 40–60% of all cases of parenchymal brain metastases. The prognosis of this disease is dismal with a median survival time of approximately 6 months. Surgical resection[for full text, please go to the a.m. URL]